Literature DB >> 8350265

Activation of muscarinic K+ current in guinea-pig atrial myocytes by a serum factor.

K Banach1, J Hüser, P Lipp, M C Wellner, L Pott.   

Abstract

1. Atrial myocytes obtained by enzymatic perfusion of hearts from adult guinea-pigs and cultured for 0-14 days were studied using the whole-cell voltage-clamp technique. 2. Superfusion of the myocytes with diluted sera (1:100 to 1:10,000) from different species (human, horse, guinea-pig) evoked an inward rectifying K+ current. The voltage-dependent properties of this current were identical to those of the K+ current activated by acetylcholine (IK(ACh)). Current density in the presence of horse serum (1:100) approximately corresponded to the non-desensitizing fraction of IK(ACh) during superfusion with 1-2 x 10(-6) M ACh. 3. During a maximal serum-evoked current, application of ACh (10(-6) M) failed to evoke additional K+ current. After switching superfusion from serum-containing to serum-free solution, the K+ current decayed 1-2 orders of magnitude slower than ACh-activated IK(ACh). During the decay of the serum-evoked current, a proportional increase in responsiveness to ACh was recorded. During submaximal activation of K+ current by serum, a saturating concentration of ACh resulted in a total current that was identical to the current evoked by ACh alone minus the desensitizing component. Thus, activation of K+ current by serum caused desensitization of IK(ACh). From these results it is concluded that sera contain a factor that activates the same population of K+ channels as ACh. 4. Irreversible activation of IK(ACh) by ACh in myocytes dialysed with the GTP-analogue GTP-gamma-S abolished sensitivity to serum and vice versa. 5. The effect of serum was not modified by atropine (10(-6) M) which completely blocked the response to 2 x 10(-6) M ACh. Furthermore, theophylline (1 mM), which completely inhibited IK(ACh) activation by adenosine (100 microM), failed to inhibit the effect of serum. Thus, neither muscarinic nor purinergic (A1) receptors are involved. 6. The peptide somatostatin (10(-6) M) and the alpha 1-agonist phenylephrine (1 microM) which previously have been shown to cause activation of IK(ACh) channels, in the present study failed to evoke any measurable current, which excludes the involvement of the corresponding receptors. 7. Pre-incubation of the cells with pertussis toxin completely abolished IK(ACh) evoked by ACh, adenosine and serum, suggesting that the activating factor, like the classical agonists, causes opening of IK(ACh) channels via a G protein (Gi, GK). 8. The potency of serum to activate IK(ACh) was not reduced by dialysis, suggesting the molecular mass of the unknown factor to be > or = 5 kDa. No activating potency was found in the dialysing solutions.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350265      PMCID: PMC1175257          DOI: 10.1113/jphysiol.1993.sp019513

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  37 in total

1.  A cardiodepressant factor isolated from blood blocks Ca2+ current in cardiomyocytes.

Authors:  S Hallström; B Koidl; U Müller; K Werdan; G Schlag
Journal:  Am J Physiol       Date:  1991-03

2.  The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart.

Authors:  D E Logothetis; Y Kurachi; J Galper; E J Neer; D E Clapham
Journal:  Nature       Date:  1987 Jan 22-28       Impact factor: 49.962

3.  Recombinant alpha i-3 subunit of G protein activates Gk-gated K+ channels.

Authors:  R Mattera; A Yatani; G E Kirsch; R Graf; K Okabe; J Olate; J Codina; A M Brown; L Birnbaumer
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

4.  On the mechanism of activation of muscarinic K+ channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins.

Authors:  Y Kurachi; T Nakajima; T Sugimoto
Journal:  Pflugers Arch       Date:  1986-09       Impact factor: 3.657

5.  Beta gamma dimers of G proteins inhibit atrial muscarinic K+ channels.

Authors:  K Okabe; A Yatani; T Evans; Y K Ho; J Codina; L Birnbaumer; A M Brown
Journal:  J Biol Chem       Date:  1990-08-05       Impact factor: 5.157

6.  Endothelin activation of an inwardly rectifying K+ current in atrial cells.

Authors:  D Kim
Journal:  Circ Res       Date:  1991-07       Impact factor: 17.367

7.  Comparison of potassium currents in rabbit atrial and ventricular cells.

Authors:  W R Giles; Y Imaizumi
Journal:  J Physiol       Date:  1988-11       Impact factor: 5.182

8.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

9.  Effects of acetylcholine and parasympathetic nerve stimulation on membrane potential in quiescent guinea-pig atria.

Authors:  H G Glitsch; L Pott
Journal:  J Physiol       Date:  1978-06       Impact factor: 5.182

10.  Alpha-adrenergic activation of the muscarinic K+ channel is mediated by arachidonic acid metabolites.

Authors:  Y Kurachi; H Ito; T Sugimoto; T Shimizu; I Miki; M Ui
Journal:  Pflugers Arch       Date:  1989-05       Impact factor: 3.657

View more
  10 in total

1.  Activation of the muscarinic K+ channel by P2-purinoceptors via pertussis toxin-sensitive G proteins in guinea-pig atrial cells.

Authors:  H Matsuura; M Sakaguchi; Y Tsuruhara; T Ehara
Journal:  J Physiol       Date:  1996-02-01       Impact factor: 5.182

2.  A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes.

Authors:  M Bünemann; K Liliom; B K Brandts; L Pott; J L Tseng; D M Desiderio; G Sun; D Miller; G Tigyi
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

3.  Activation of muscarinic K+ current in guinea-pig atrial myocytes by sphingosine-1-phosphate.

Authors:  M Bünemann; B Brandts; D M zu Heringdorf; C J van Koppen; K H Jakobs; L Pott
Journal:  J Physiol       Date:  1995-12-15       Impact factor: 5.182

4.  Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors.

Authors:  K Liliom; G Sun; M Bünemann; T Virág; N Nusser; D L Baker; D A Wang; M J Fabian; B Brandts; K Bender; A Eickel; K U Malik; D D Miller; D M Desiderio; G Tigyi; L Pott
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

5.  Membrane-delimited activation of muscarinic K current by an albumin-associated factor in guinea-pig atrial myocytes.

Authors:  M Bünemann; L Pott
Journal:  Pflugers Arch       Date:  1993-11       Impact factor: 3.657

6.  Serum contains a potent factor that decreases beta-adrenergic receptor-stimulated L-type Ca2+ current in cardiac myocytes.

Authors:  K Banach; M Bünemann; J Hüser; L Pott
Journal:  Pflugers Arch       Date:  1993-05       Impact factor: 3.657

7.  Downregulation of muscarinic M2 receptors linked to K+ current in cultured guinea-pig atrial myocytes.

Authors:  M Bünemann; B Brandts; L Pott
Journal:  J Physiol       Date:  1996-07-15       Impact factor: 5.182

8.  Diadenosine-5-phosphate exerts A1-receptor-mediated proarrhythmic effects in rabbit atrial myocardium.

Authors:  B Brandts; R Borchard; D Dirkmann; I Wickenbrock; B Sievers; M van Bracht; M W Prull; H-J Trappe
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

9.  Down-regulation of A1 adenosine receptors coupled to muscarinic K+ current in cultured guinea-pig atrial myocytes.

Authors:  M Bünemann; L Pott
Journal:  J Physiol       Date:  1995-01-01       Impact factor: 5.182

10.  Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria.

Authors:  Bruno Bragança; Nádia Oliveira-Monteiro; Fátima Ferreirinha; Pedro A Lima; Miguel Faria; Ana P Fontes-Sousa; Paulo Correia-de-Sá
Journal:  Front Pharmacol       Date:  2016-03-07       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.